The effect of misoprostol on myomectomy
Not Applicable
- Conditions
- terine myoma.Leiomyoma of uterus, unspecified
- Registration Number
- IRCT2014050210901N6
- Lead Sponsor
- Female Reproductive Research Center, Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 105
Inclusion Criteria
the desire to participate in the study
Exclusion Criteria
allergy to misoprostol or oxytocin; hormone therapy before surgery or gonadotropin releasing drugs such as oral contraceptive pills; active liver disorders - kidney disease - heart - lung ; candidates hysteroscopic myomectomy; hypertension ;coagulopathy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bleeding. Timepoint: Day intervention. Method of measurement: The blood volume (amount of suction blood and blood absorbed in sponges to longGas 50cc and gas 5cc ).
- Secondary Outcome Measures
Name Time Method Duration of hospital stay. Timepoint: Since the intervention to patient discharge from the hospital. Method of measurement: documentation in the file.;Duration of surgery. Timepoint: Begin operation until the completion of surgery. Method of measurement: documentation in the file.;Hemoglubin 6 hours after Surgery. Timepoint: 6 hours after intervention. Method of measurement: Testing the file.;Hemoglubin 24 hour after surgery. Timepoint: 24 hours after intervention. Method of measurement: Testing the file.;Blood transfusion. Timepoint: Since the intervention to patient discharge from the hospital. Method of measurement: documentation in the file.